{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:58:32Z","timestamp":1790017112411,"version":"4.0.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>We tested the hypothesis that ciprofloxacin exposure increases the incidence of aortic dissection and arterial rupture in vascular Ehlers-Danlos (vEDS) mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>While data support that fluoroquinolones exacerbate lethal sequela in some types of aortic pathology, the potential danger of these drugs has not been studied in the context of vEDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Eight-week-old male and female vEDS mice (\n                      <jats:italic toggle=\"yes\">Col3a1[G209S\/WT]<\/jats:italic>\n                      ) and wild-type littermates (\n                      <jats:italic toggle=\"yes\">Col3a1[WT\/WT]<\/jats:italic>\n                      ) were randomly assigned to receive either ciprofloxacin (n=25) or vehicle control (n=24) through daily gavage for 2 weeks and were monitored for 4 weeks. We compared groups based on survival, aortic dissection and rupture incidence, and aortic tissue levels of collagen, lysyl oxidase (LOX), matrix metalloproteinases (MMP), macrophages, and apoptosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      All vEDS mice that received vehicle and all littermate controls survived the 4-week study period. In contrast, 44% of vEDS mice that received ciprofloxacin died (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) due to aortic or arterial rupture manifesting as hemopericardium or hemothorax, most within 7 days of exposure. Findings were similar in male and female vEDS mice. Compared with aortic tissue from vehicle-treated vEDS mice, tissue from ciprofloxacin-treated vEDS mice exhibited decreased collagen content, decreased LOX, increased MMP2 and 9 levels, increased macrophage infiltration, and increased apoptosis (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In a mouse model of vEDS, ciprofloxacin exposure resulted in aortic inflammation, collagen disruption, cell death, reduced LOX, and increased risk of fatal dissection and rupture of the aorta and branch arteries. These novel translational findings strongly support recommendations to avoid fluoroquinolones in patients with vEDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000007133","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:04:14Z","timestamp":1781697854000},"page":"516-526","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Ciprofloxacin Exposure Promotes Aortic Dissection and Arterial Rupture in a Mouse Model of Vascular Ehlers-Danlos Syndrome"],"prefix":"10.1097","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8736-4266","authenticated-orcid":false,"given":"Scott A.","family":"LeMaire","sequence":"first","affiliation":[{"name":"Departments of Investigational Medicine and Cardiothoracic Surgery, Geisinger College of Health Sciences, Danville, PA"},{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Vela","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Coselli","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[{"name":"Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"R1-20260919","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/gim.2014.72","article-title":"Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV)","volume":"16","author":"Pepin","year":"2014","journal-title":"Genet Med"},{"key":"R2-20260919","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31553","article-title":"Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome","volume":"175","author":"Byers","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R3-20260919","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jvs.2005.03.053","article-title":"The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience","volume":"42","author":"Oderich","year":"2005","journal-title":"J Vasc Surg"},{"key":"R4-20260919","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/ejhg.2015.32","article-title":"The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome","volume":"23","author":"Frank","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R5-20260919","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jacc.2019.01.058","article-title":"Vascular Ehlers-Danlos syndrome: Long-term observational study","volume":"73","author":"Frank","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260919","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jvs.2019.01.069","article-title":"A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome","volume":"70","author":"Shalhub","year":"2019","journal-title":"J Vasc Surg"},{"key":"R7-20260919","doi-asserted-by":"crossref","first-page":"e010077","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"R8-20260919","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.amjmed.2017.06.029","article-title":"Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis","volume":"130","author":"Singh","year":"2017","journal-title":"Am J Med"},{"key":"R9-20260919","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","article-title":"Oral fluoroquinolone and the risk of aortic dissection","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R10-20260919","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","article-title":"Association of fluoroquinolone use with short-term risk of development of aortic aneurysm","volume":"156","author":"Newton","year":"2021","journal-title":"JAMA Surg"},{"key":"R13-20260919","doi-asserted-by":"crossref","first-page":"e181804","DOI":"10.1001\/jamasurg.2018.1804","article-title":"Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice","volume":"153","author":"LeMaire","year":"2018","journal-title":"JAMA Surg"},{"key":"R14-20260919","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jtcvs.2020.09.069","article-title":"Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice","volume":"163","author":"LeMaire","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R15-20260919","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1172\/JCI130730","article-title":"Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome","volume":"130","author":"Bowen","year":"2020","journal-title":"J Clin Invest"},{"key":"R16-20260919","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"R17-20260919","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-017-12248-z","article-title":"Critical role of ADAMTS-4 in the development of sporadic aortic aneurysm and dissection in mice","volume":"7","author":"Ren","year":"2017","journal-title":"Sci Rep"},{"key":"R18-20260919","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/ATVBAHA.116.307648","article-title":"NLRP3-caspase-1 inflammasome degrades contractile proteins: Implications for aortic biomechanical dysfunction and aneurysm and dissection formation","volume":"37","author":"Wu","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R19-20260919","doi-asserted-by":"crossref","first-page":"e014044","DOI":"10.1161\/JAHA.119.014044","article-title":"Targeting the NLRP3 inflammasome with inhibitor MCC950 prevents aortic aneurysms and dissections in mice","volume":"9","author":"Ren","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R20-20260919","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.041460","article-title":"Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture","volume":"141","author":"Luo","year":"2020","journal-title":"Circulation"},{"key":"R21-20260919","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/ATVBAHA.117.309017","article-title":"STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity","volume":"37","author":"Mao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-20260919","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.123.063332","article-title":"Epigenetic induction of smooth muscle cell phenotypic alterations in aortic aneurysms and dissections","volume":"148","author":"Chakraborty","year":"2023","journal-title":"Circulation"},{"key":"R24-20260919","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/j.semtcvs.2021.01.051","article-title":"Commentary: fluoroquinolones and aortic complications: are we ready for a class III recommendation with level Z evidence?","volume":"33","author":"LeMaire","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R25-20260919","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.jacc.2021.03.004","article-title":"Fluoroquinolones in patients with aortic aneurysms or dissections: pouring gasoline on a fire","volume":"77","author":"LeMaire","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R26-20260919","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1253\/circj.CJ-22-0682","article-title":"Fluoroquinolones and risk of aortic aneurysm or dissection in patients with congenital aortic disease and Marfan syndrome","volume":"87","author":"Chen","year":"2023","journal-title":"Circ J"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0000000000007133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:04:22Z","timestamp":1789779862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0000000000007133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000007133","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"2026-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}